Results 91 to 100 of about 3,662,534 (344)
History of evidence-based medicine
Indian Journal of Urology, 2011 This essay reviews the historical circumstances surrounding the introduction and evolution of evidence-based medicine. Criticisms of the approach are also considered.
Roger L Sur, Philipp Dahm
doaj +1 more source
Making Medical History Relevant to Medical Students: The First Fifty Years of the Calgary History of Medicine Program and History of Medicine Days Conferences. [PDF]
J Hist Med Allied Sci, 2023 Stahnisch FW.
europepmc +1 more source
Current status of herbal and their future perspectives [PDF]
, 2007 Traditional medicine is the synthesis of therapeutic experience of generations of practicing physicians of indigenous systems of medicine. Throughout the history of mankind, many infectious diseases have been treated with herbals.
Ponnampalam Gopalakrishnakone +1 more
core +1 more source
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM
Molecular Oncology, EarlyView.CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak +14 more
wiley +1 more source
A History of Medicine. Volume I. Primitive and Archaic Medicine [PDF]
, 1956 William N. Fenton
openalex +2 more sources
Clinical Applications of the History of Medicine in Muslim-Majority Nations. [PDF]
J Hist Med Allied Sci, 2023 Weber AS.
europepmc +1 more source
The History of Preventive Medicine in World War II [PDF]
, 1959 Tom F. Whayne
openalex +1 more source
, 2004 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2004. ©The Trustee of the Wellcome Trust, London, 2004. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated ...
Christie, DA, Tansey, EM
core
Molecular Oncology, EarlyView.This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini +10 more
wiley +1 more source
Doctors should do history of medicine… properly. [PDF]
J R Soc Med, 2022 Hilton C.
europepmc +1 more source